WriteResult®, a leading provider of Electronic Patient Outcome (ePRO) solutions, announced today that it has expanded its myPROpad™ ePRO tablet with the addition of a touchscreen version of the EQ-5D-5L, one of the most widely used and well-respected Patient Reported Outcome (PRO) instruments available for measuring general health status. The EQ-5D is used during clinical trials and in other health care settings to generate a measure that can be used to demonstrate Health-Related Quality of Life outcomes (HRQoL) resulting from a specific treatment or intervention, and as a key component in cost-effectiveness analyses.
myPROpad is an iPad®-based data collection solution designed for use in the Pharmaceutical industry that has broad application in almost any situation where data collection forms are traditionally completed on paper. By transforming standardized forms into user-friendly touchscreens for the iPad, myPROpad makes the collection of data easier and more engaging for patients, which in turn leads to better compliance and higher quality data. WriteResult has implemented its innovative ePRO options in large, multi-center global registration trials. "Researchers who have been looking for a touchscreen approach to the EQ-5D have an option now using myPROpad that they didn't have before," states
WriteResult offers full-service data management solutions for clinical research through the collection and verification of ePROs leveraging digital pen and iPad-based technologies. Since 2006 WriteResult has partnered with study sponsors to deliver simple and effective ePRO solutions -- rapid study startup with clean, real-time data using technologies that are intuitive for sites and patients.
For more information about WriteResult, please contact
iPad is a registered trademark of
Established in 1987, the
For more information on EuroQol or the EQ-5D please contact: userinformationservice(at)euroqol(dot)org or via telephone at +31 884400190.
Read the full story at http://www.prweb.com/releases/2014/08/prweb12106707.htm
Most Popular Stories
- Pickup Discounts Boost September Auto Sales
- Kurdish Militia Still Lack Weapons, Training
- Review: Pay by Phone or Just Keep Using Plastic?
- Lexus Luxury Compact Sedan Wins Buyers
- N.Y. Ups Awards of State Contracts to Minorities
- Ebola Victim Was Sent Home by Dallas Hospital
- Dallas Parents Fear Students Exposed to Ebola
- Group Offers Online Help for College Students
- Baker Hughes to Disclose Fracking Chemicals
- Why the Bond Market Isn't as Safe as You Think